checkAd
    Startseite > Aktien > Cara Therapeutics > Nachrichten
    Cara Therapeutics Aktie
    0,6540
     
    EUR
    +3,48 %
    +0,0220 EUR
    Letzter Kurs 25.04.24 Tradegate
    0,6195
     
    EUR
    6.460 STK
    Geldkurs 10:34:30
    0,6985
     
    EUR
    5.777 STK
    Briefkurs 10:34:30
    ISIN: US1407551092 · WKN: A1XDTK · SYM: 69C · USA

    Neueste Nachrichten

    Cara Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
    02.04.24 · globenewswire · Cara Therapeutics
    Cara Therapeutics to Host Notalgia Paresthetica (NP) Virtual KOL Event on Wednesday, March 27, 2024
    07.03.24 · globenewswire · Cara Therapeutics
    Cara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results
    04.03.24 · globenewswire · Cara Therapeutics
    Cara Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024
    12.02.24 · globenewswire · Cara Therapeutics
    Cara Therapeutics Prioritizes Late-Stage Notalgia Paresthetica Program and Extends Cash Runway into 2026
    22.01.24 · globenewswire · Cara Therapeutics
    Cara Therapeutics Announces Outcome from Dose-Finding Part A of KIND 1 Study Evaluating Oral Difelikefalin for Moderate-to-Severe Pruritus in Patients with Atopic Dermatitis
    18.12.23 · globenewswire · Cara Therapeutics
    Cara Therapeutics Reports Third Quarter 2023 Financial Results
    13.11.23 · globenewswire · Cara Therapeutics
    Wer wird die neue BioNTech?: Diese 3 Biotech-Aktien könnten um über 500% explodieren - Werden sie die neuen BioNTechs?
    10.11.23 · wallstreetONLINE NewsUpdate · Cara Therapeutics
    Wer wird die neue BioNTech?: Biotech-Kursraketen: Diese Aktien können um über 500 Prozent steigen!
    10.11.23 · wallstreetONLINE Redaktion · Cara Therapeutics
    Cara Therapeutics Announces up to $40.0 Million Non-Dilutive Financing Agreement with HealthCare Royalty
    02.11.23 · globenewswire · Cara Therapeutics
    Cara Therapeutics to Announce Third Quarter 2023 Financial Results on November 13, 2023
    23.10.23 · globenewswire · Cara Therapeutics
    Cara Therapeutics Announces Approval of KORSUVA IV Injection Syringe in Japan for the Treatment of Pruritus in Hemodialysis Patients
    25.09.23 · globenewswire · Cara Therapeutics